Royalty Pharma plc (NASDAQ:RPRX) shares, rose in value on Wednesday, January 22, with the stock price down by -0.73% to the previous day’s close as strong demand from buyers drove the stock to $30.08.
Actively observing the price movement in the last trading, the stock closed the session at $30.30, falling within a range of $29.73 and $30.21. The value of beta (5-year monthly) was 0.466 whereas the PE ratio was 11.77 over 12-month period. Referring to stock’s 52-week performance, its high was $31.66, and the low was $24.05. On the whole, RPRX has fluctuated by 22.93% over the past month.
With the market capitalization of Royalty Pharma plc currently standing at about $17.72 billion, investors are eagerly awaiting this quarter’s results, scheduled for in February. The company’s Forward Dividend Ratio is 0.84, with its dividend yield at 2.79%.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 2.65B, with a low estimate of 443.16M and a high estimate of 732M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 622.43M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that RPRX’s technical picture suggests that short-term indicators denote the stock is a 100% Buy on average. However, medium-term indicators have put the stock in the category of 50% Sell while long-term indicators on average have been pointing out that it is a 50% Buy.
The stock’s technical analysis shows that the PEG ratio is about 1.18, with the price of RPRX currently trading nearly 9.56% and 13.50% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 72.63, while the 7-day volatility ratio is showing 2.24% which for the 30-day chart, stands at 2.33%. Furthermore, Royalty Pharma plc (RPRX)’s beta value is 0.49, and its average true range (ATR) is 0.72.
A comparison of Royalty Pharma plc (RPRX) with its peers suggests the former has fared considerably weaker in the market. RPRX showed an intraday change of -0.73% in last session, and over the past year, it grew by 3.47%%.
Data on historical trading for Royalty Pharma plc (NASDAQ:RPRX) indicates that the trading volumes over the past 10 days have averaged 4.4 and over the past 3 months, they’ve averaged 3.22 million. According to company’s latest data on outstanding shares, there are 446.04 million shares outstanding.
Nearly 14.35% of Royalty Pharma plc’s shares belong to company insiders and institutional investors own 70.62% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 16.56 million shares as on 2024-12-31, resulting in a short ratio of 5.21. According to the data, the short interest in Royalty Pharma plc (RPRX) stood at 387.00 of shares outstanding as of 2024-12-31; the number of short shares registered in 2024-11-29 reached 15.7 million. The stock has risen by 17.91% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the RPRX stock heading into the next quarter.
